Diamonds and Dogs
9/10/12Geron Corporation (GERN)
Geron Corporation lost over half of its value today, down 55.86% at $1.28. The pharmaceutical company saw its shares get demolished after announcing two setbacks for its experimental cancer drug, imetelstat. Geron ended a mid-stage trial of imetelstat as a treatment for breast cancer because women who were treated with the drug were not doing as well as those who were treated with only a standard chemotherapy drug. The company said women who were treated with imetelstat and paclitaxel had a shorter time to death or disease progression than patients who received only paclitaxel. Geron won't be curing cancer with this trial, and shares are showing the disappointment down to a new 52-week low.
Green Mountain Coffee Roasters Inc. (GMCR)
Green Mountain gave investors a buzz today, up 9.09% at $30.36. The company saw its shares continue to rally today after announcing late last week that would release a new line of health drinks. The maker of the Keurig single-serve coffee system and its related coffee pods announced Thursday that it will soon roll out coffee, tea and fruit drinks that include antioxidants and vitamins which are intended to appeal to today's more health-conscious consumers and diversify its product line. Green Mountain is expecting to double the number of Keurig's in use in the US, to around 25 million, over the next two years. Shares were trading at 3 times its average volume, at 20 million shares today.
Diamonds and Dogs market commentary is a journal of daily observations on anything that happens to be of interest to our author. Obviously, our primary focus is the stock market and world economic events, but for this page we have no defined topics. We want this page to be dedicated to the interests, concerns, and possibly to the financial gain of our clients and friends. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.